Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedOvarian cancer is added as a related topic and MedlinePlus Genetics is listed under related topics. The site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check24 days agoChange DetectedOvarian cancer and the MedlinePlus Genetics related topics have been removed from the study page.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible study content or navigation changes are apparent.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study status updated to Recruiting on 2026-02-12, replacing Not yet recruiting; the record revision advanced from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check75 days agoChange DetectedReplaced the 'Last Update Posted (Estimated)' label with a plain 'Last Update Posted' label on the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.